eCite Digital Repository

Strontium ranelate, a promising disease modifying osteoarthritis drug


Han, W and Fan, S and Bai, X and Ding, C, Strontium ranelate, a promising disease modifying osteoarthritis drug, Expert Opinion on Investigational Drugs, 26, (3) pp. 375-380. ISSN 1354-3784 (2017) [Refereed Article]

Copyright Statement

2017 Informa UK

DOI: doi:10.1080/13543784.2017.1283403


Introduction: The articular cartilage and subchondral bone may have potential crosstalk in the development and progression of osteoarthritis (OA). Strontium ranelate (SrR) has the ability to dissociate the bone remodeling process and to change the balance between bone resorption and bone formation. Its effect on subchondral bone makes it a potential disease- modifying osteoarthritis drug (DMOAD) in the treatment of OA. The aim of the current review is to summarize up-to-date pharmacological and clinical data of SrR for OA treatment.

Areas covered: A literature search was performed on PubMed and European Medicines Agency (EMA) website for all publications and documents related to SrR and OA. References of related studies were searched by hand. Treatment with SrR, especially at the dosage of 2 g/day, was associated with reduced radiographic knee OA progression, and with meaningful clinical improvement. It was also significantly associated with decreased MRI-assessed cartilage volume loss (CVL) and bone marrow lesions (BMLs).

Expert opinion: SrR could be a promising DMOAD particularly for OA patients with bone phenotypes. The clinical efficacy and side effects of SrR for OA treatment need to be further investigated in future clinical trials before clinical application.

Item Details

Item Type:Refereed Article
Keywords:Strontium ranelate, disease-modifying osteoarthritis drug (DMOAD), osteoarthritis (OA)
Research Division:Biomedical and Clinical Sciences
Research Group:Clinical sciences
Research Field:Rheumatology and arthritis
Objective Division:Health
Objective Group:Clinical health
Objective Field:Clinical health not elsewhere classified
UTAS Author:Ding, C (Professor Chang-Hai Ding)
ID Code:124288
Year Published:2017
Web of Science® Times Cited:22
Deposited By:Menzies Institute for Medical Research
Deposited On:2018-02-16
Last Modified:2018-07-20

Repository Staff Only: item control page